These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30288018)

  • 1. Murrangatin suppresses angiogenesis induced by tumor cell-derived media and inhibits AKT activation in zebrafish and endothelial cells.
    Long W; Wang M; Luo X; Huang G; Chen J
    Drug Des Devel Ther; 2018; 12():3107-3115. PubMed ID: 30288018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
    J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
    Lien JC; Chung CL; Huang TF; Chang TC; Chen KC; Gao GY; Hsu MJ; Huang SW
    Br J Pharmacol; 2019 Oct; 176(20):4034-4049. PubMed ID: 31368127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells.
    Di Martile M; Gabellini C; Desideri M; Matraxia M; Farini V; Valentini E; Carradori S; Ercolani C; Buglioni S; Secci D; Andreazzoli M; Del Bufalo D; Trisciuoglio D
    J Exp Clin Cancer Res; 2020 Jun; 39(1):103. PubMed ID: 32498717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G; Sun L; Pei Y; Wang D
    Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4'-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling.
    Sun D; Zhang F; Qian J; Shen W; Fan H; Tan J; Li L; Xu C; Yang Y; Cheng H
    Chem Biol Interact; 2018 Dec; 296():26-33. PubMed ID: 30217479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic activity of para-coumaric acid methyl ester on HUVECs in vitro and zebrafish in vivo.
    Zhang HZ; Li CY; Wu JQ; Wang RX; Wei P; Liu MH; He MF
    Phytomedicine; 2018 Sep; 48():10-20. PubMed ID: 30195867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo.
    Zhou ZY; Zhao WR; Xiao Y; Zhou XM; Huang C; Shi WT; Zhang J; Ye Q; Chen XL; Tang JY
    Acta Pharmacol Sin; 2020 Feb; 41(2):260-269. PubMed ID: 31515528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer activity of an osthole derivative, NBM-T-BMX-OS01: targeting vascular endothelial growth factor receptor signaling and angiogenesis.
    Yang HY; Hsu YF; Chiu PT; Ho SJ; Wang CH; Chi CC; Huang YH; Lee CF; Li YS; Ou G; Hsu MJ
    PLoS One; 2013; 8(11):e81592. PubMed ID: 24312323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoindolone derivative QSN-10c induces leukemic cell apoptosis and suppresses angiogenesis via PI3K/AKT signaling pathway inhibition.
    Lv WW; Qin SN; Chen CQ; Zhang JJ; Ren TS; Xu YN; Zhao QC
    Acta Pharmacol Sin; 2014 May; 35(5):625-35. PubMed ID: 24786233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cells.
    Lin C; Wu M; Dong J
    PLoS One; 2012; 7(2):e31708. PubMed ID: 22348123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
    Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barbigerone inhibits tumor angiogenesis, growth and metastasis in melanoma.
    Yang JH; Hu J; Wan L; Chen LJ
    Asian Pac J Cancer Prev; 2014; 15(1):167-74. PubMed ID: 24528020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y; Peng A; He S; Shao X; Nie C; Chen L
    J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of agnuside, a natural proangiogenic small molecule.
    Pillarisetti P; Myers KA
    Eur J Med Chem; 2018 Dec; 160():193-206. PubMed ID: 30340142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by different growth factors.
    Trenti A; Zulato E; Pasqualini L; Indraccolo S; Bolego C; Trevisi L
    Br J Pharmacol; 2017 Sep; 174(18):3094-3106. PubMed ID: 28688145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.